未登录

M

Maureen K. Hahn

Florida Atlantic University

H指数:22

被引数:2,320

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Elesclomol Diminishes Redox Imbalance in Peripheral Tissues of Mblac1 Knockout Mice

Elesclomol 减轻 Mblac1 基因敲除小鼠外周组织的氧化还原失衡

Journal of Biophotonics

IF2.3

2026-01-010

PRE

Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout Mice

IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE

IF4.4

2024-01-013

OAAI

Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters

MOLECULAR PSYCHIATRY

IF10.1

2022-09-186

PRE

There's no place like home? Return to the home cage triggers dopamine release in the mouse nucleus accumbens

NEUROCHEMISTRY INTERNATIONAL

IF4

2021-01-015

OAAI

Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice

NEUROPSYCHOPHARMACOLOGY

IF7.1

2018-12-2116

OAAI

Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine

交感神经元相关巨噬细胞通过输入和代谢去甲肾上腺素导致肥胖

NATURE MEDICINE

IF50

2017-10-09359

OAAI

The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2014-10-2062

OAAI

Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders

对多巴胺的良好摆脱: 多巴胺转运蛋白在突触功能和多巴胺相关脑部疾病中的作用

NEUROCHEMISTRY INTERNATIONAL

IF4

2014-07-0160

PREAI

Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder

NEUROCHEMISTRY INTERNATIONAL

IF4

2014-07-0129

OA

Extracellular Norepinephrine Clearance by the Norepinephrine Transporter Is Required for Skeletal Homeostasis

骨骼稳态需要去甲肾上腺素转运蛋白清除细胞外去甲肾上腺素

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2013-10-0158

OAAI

Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome

DISEASE MODELS & MECHANISMS

IF3.3

2013-01-0120

OAAI

Intracerebroventricular olanzapine acutely suppresses β-cell secretion in vivo: an animal model

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2011-09-010

PREAI

Atypical antipsychotics and effects of muscarinic and serotonergic receptor binding on insulin secretion in a rat model

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2010-08-010

PREAI

Choline transporter gene variation is associated with attention-deficit hyperactivity disorder

JOURNAL OF NEURODEVELOPMENTAL DISORDERS

IF4

2009-08-2855

OAAI

The functional impact of SLC6 transporter genetic variation

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY

IF13.1

2007-02-01116

PREAI

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2006-12-12133

OAAI

Genetic basis of clinical catecholamine disorders

CHROMAFFIN CELL: TRANSMITTER BIOSYNTHESIS, STORAGE, RELEASE, ACTIONS, AND INFORMATICS

IF0

2006-01-2418

PREAI

Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation

MOLECULAR PHARMACOLOGY

IF3

2005-08-0173

PREAI

Hereditary dysautonomias: current knowledge and collaborations for the future

CLINICAL AUTONOMIC RESEARCH

IF3.4

2003-06-011

PREAI

Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

1998-05-0120

PREAI